Lubiprostone (rINN marketed under the trade name Amitiza) is a medication used in the management of chronic idiopathic constipation predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006.
This page contains content from the copyrighted Wikipedia article "Lubiprostone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
